The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 07, 2021

Filed:

Sep. 27, 2019
Applicant:

H. Lundbeck A/s, Valby, DK;

Inventors:

Jan Torleif Pedersen, Valby, DK;

Kristian Kjaergaard, Valby, DK;

Lars Østergaard Pedersen, Valby, DK;

Ayodeji Abdur-Rasheed Asuni, Valby, DK;

Nina Helen Rosenqvist, Valby, DK;

Justus Claus Alfred Daechsel, Valby, DK;

Karsten Juhl, Greve, DK;

Lena Tagmose, Lyngby, DK;

Mauro Marigo, Skovlunde, DK;

Thomas Jensen, Copenhagen, DK;

Søren Christensen, Valby, DK;

Laurent David, Valby, DK;

Christiane Volbracht, Valby, DK;

Lone Helboe, Valby, DK;

Assignee:

H. Lundbeck A/S, Valby, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/395 (2006.01); A61K 49/00 (2006.01); G01N 33/68 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 39/395 (2013.01); A61K 49/00 (2013.01); G01N 33/6896 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/30 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/565 (2013.01); C07K 2317/75 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); G01N 2800/2814 (2013.01); G01N 2800/2821 (2013.01);
Abstract

The present invention relates to a class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396) with improved affinity, as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer's disease and other tauopathies.


Find Patent Forward Citations

Loading…